Skip to main content
SpringerLink
Log in

The heterogeneity of ovarian cancer

  • News and Views
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Ovarian cancer carries the worst prognosis of all gynecological malignancies. This is mainly due to its resistance against commonly used cytostatic drugs as well as the lack of a screening method for its detection at an early stage. Both basic and translational research have shown over the past decades that ovarian cancer as a medical term includes several types of tumors with different phenotypes, molecular biology, etiology, tumor progression, and even different prognosis. In this issue of Archives of Gynecology and Obstetrics, J. Dietel presents a review article about novel findings of the etiopathogenesis of ovarian cancer and the role that fallopian tubes may play. He also outlines the implied clinical consequences. Here, we give a brief overview of the heterogeneity of ovarian cancer to introduce the topic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Shih Ie M, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164(5):1511–1518

    Article  PubMed  Google Scholar 

  2. Du Bois A, Ewald-Riegler N et al (2009) Borderline-Tumoren des Ovars—eine systematische übersicht. Geburtsh Frauenheilk 69:807–833

    Article  Google Scholar 

  3. Seidman JD, Kurman RJ (2000) Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 31(5):539–557

    Article  CAS  PubMed  Google Scholar 

  4. Kurman RJ, Shih Ie M (2010) The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34(3):433–443

    Article  PubMed Central  PubMed  Google Scholar 

  5. Kurman RJ, Shih Ie M (2008) Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 27(2):151–160

    PubMed Central  PubMed  Google Scholar 

  6. Heintz AP, Odicino F et al (2006) Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95(Suppl 1):161–192

    Article  Google Scholar 

  7. Meinhold-Heerlein I, Bauerschlag D et al (2005) Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential. Oncogene 24(6):1053–1065

    Article  CAS  PubMed  Google Scholar 

  8. Fleming JS, Beaugie CR et al (2006) Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol 247(1–2):4–21

    Article  CAS  PubMed  Google Scholar 

  9. Jazaeri AA (2009) Molecular profiles of hereditary epithelial ovarian cancers and their implications for the biology of this disease. Mol Oncol 3(2):151–156

    Article  CAS  PubMed  Google Scholar 

  10. Bauerschlag DO, Schem C et al (2009) The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer. J Cancer Res Clin Oncol 136(1):79–88

    Article  Google Scholar 

  11. Hauptmann S, Denkert C et al (2002) Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization. Hum Pathol 33(6):632–641

    Article  CAS  PubMed  Google Scholar 

  12. Shih Ie M, Kurman RJ (2005) Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin Cancer Res 11(20):7273–7279

    Article  PubMed  Google Scholar 

  13. Hennessy BT, Coleman RL et al (2009) Ovarian cancer. Lancet 374(9698):1371–1382

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

There is no conflict of interest for both authors.

Author information

Authors and Affiliations

  1. Department of Gynecology and Obstetrics, University Hospital Aachen, Pauwelsstraße 30, 52074, Aachen, Germany

    I. Meinhold-Heerlein & S. Hauptmann

  2. Institute of Pathology, Hospital Düren, Düren, Germany

    I. Meinhold-Heerlein & S. Hauptmann

Authors
  1. I. Meinhold-Heerlein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Hauptmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. Meinhold-Heerlein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meinhold-Heerlein, I., Hauptmann, S. The heterogeneity of ovarian cancer. Arch Gynecol Obstet 289, 237–239 (2014). https://doi.org/10.1007/s00404-013-3114-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-013-3114-3

Keywords

Search

Navigation